Foreign bulk ingredient plants have 17% non-compliance rate following FDA inspections.
This article was originally published in The Tan Sheet
Executive Summary
FOREIGN BULK PLANT INSPECTIONS HAVE 17% GMP NON-COMPLIANCE RATE over a two-year period. Of the 368 inspections of active pharmaceutical ingredient manufacturers in the two years, 61 (17%) resulted in non-compliance letters from FDA compared to 16 (11%) of the 152 inspections conducted in finished product plants, according to a survey of agency compliance letters sent to foreign companies between FY 1995 and FY 1996.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning